Table of Content

1. Introduction


2. Research & Methodology

3. Executive Summary


4. Market Dynamics

4.1 Growth Driver
4.2 Challenges


5. Australia Diabetes Market


6. Australia Diabetes Population

6.1 Type 1 & Type 2 Diabetes Population and Forecast


7. Market Share Analysis – Australia Diabetic

7.1 By Types


8. Continuous Glucose Monitoring Market (CGM) – Australia Market & Users

8.1 Australia - CGM Market by Components

8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast

8.2 Australia – CGM User (2011 – 2025)
8.3 CGM Reimbursement in Australia


9. Blood Glucose Device (SMBG) – Australia Market & Users

9.1 Market

9.1.1 Type 1 & Type 2 (Diabetes)

9.2 Test Strips Market and Forecast

9.2.1 Type 1 & Type 2 (Diabetes)

9.3 Lancet Market and Forecast

9.3.1 Type 1 & Type 2 (Diabetes)

9.4 Meter Market and Forecast

9.4.1 Type 1 & Type 2 (Diabetes)

9.5 Blood Glucose Device (SMBG) Users

9.5.1 Type 1 & Type 2 (Diabetes)

9.6 Reimbursement of Blood Glucose Devices in Australia


10. Insulin Pen Market & User Analysis

10.1 Insulin Pen User

10.1.1 Disposable Insulin Pen Users
10.1.2 Reusable Insulin Pen Users
10.1.3 Smart Insulin Pen Users

10.2 Insulin Pen Market

10.2.1 Disposable Insulin Pen Market
10.2.2 Reusable Insulin Pen Market
10.2.3 Smart Insulin Pen Market

10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies


11. Insulin Pump Market & Users & Forecast

11.1 Insulin Pump Users & Forecast

11.1.1 Type 1 & Type 2 (Insulin Pump User & Forecast)

11.2 Insulin Pump Market & Forecast

11.2.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)

11.3 Differentiation Points of Insulin Pump Products in Australia

11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo

11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

11.4.1 Medtronic

11.5 Insulet Corporation

11.5.1 Training Structure for New Patients - Insulet Corporation

11.6 Animas Corporation

11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)

11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump


12. Insulin Pen – Company Analysis

12.1 B. Braun Melsungen AG

12.1.1 Overview
12.1.2 Initiatives & Recent Developments
12.1.3 Revenue

12.2 Eli Lilly

12.2.1 Overview
12.2.2 Initiatives & Recent Developments
12.2.3 Revenue

12.3 Artsana S.p.A.,

12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue

12.4 BD

12.4.1 Overview
12.4.2 Initiatives & Recent Developments
12.4.3 Revenue

12.5 Novo Nordisk A/S

12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue

12.6 Owen Mumford Ltd.

12.6.1 Overview
12.6.2 Initiatives & Recent Developments
12.6.3 Revenue

12.7 Ypsomed AG

12.7.1 Overview
12.7.2 Initiatives & Recent Developments
12.7.3 Revenue


13. Insulin Pump – Company Analysis

13.1 Medtronic

13.1.1 Overview
13.1.2 Insulin Pump – Product Details
13.1.3 Insulin Pump – Latest Development & Trends
13.1.4 Revenue

13.2 Insulet Corporation

13.2.1 Overview
13.2.2 Insulin Pump – Product Details
13.2.3 Revenue


14. SMBG – Company Analysis

14.1 LifeScan Inc.

14.1.1 Overview
14.1.2 Revenue & Forecast

14.2 Abbott Laboratories

14.2.1 Overview
14.2.2 Abbott Laboratories SMBG Revenue & Forecast


15. CGM – Company Analysis

15.1 Dexcom Inc

15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue& Forecast

15.2 Abbott Laboratories

15.2.1 Overview
15.2.2 Recent Development

15.3 Roche

15.3.1 Overview
15.3.2 Recent Development



List of Figures



Figure 4_1: Global Ageing Population (Billion) 2015 – 2050
Figure 5_1: Australia – Diabetic Market (Billion US$), 2015 – 2019
Figure 5_2: Australia – Forecast for Market (Billion US$), 2020 – 2025
Figure 6_1: Australia – Diabetes Population (Thousand), 2011 – 2019
Figure 6_2: Australia– Forecast for Diabetes Population (Thousand), 2020 – 2025
Figure 6_3: Australia – Type 1 & Type 2 Diabetes Population (Thousand), 2011 – 2019
Figure 6_4: Australia – Forecast for Type 1 & Type 2 Diabetes Population (Thousand), 2020 – 2025
Figure 9_1: Australia – Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2013 – 2019
Figure 9_2: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2020 – 2025
Figure 9_3: Australia – Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2013 – 2019
Figure 9_4: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_5: Australia – Blood Glucose Test Strips Market (Million US$), 2013– 2019
Figure 9_6: Australia – Forecast for Blood Glucose Test Strips Market (Million US$), 2020 – 2025
Figure 9_7: Australia – Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2013 – 2019
Figure 9_8: Australia – Forecast for Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_9: Australia – Blood Glucose Lancet Market (Million US$), 2013 – 2019
Figure 9_10: Australia – Forecast for Blood Glucose Lancet Market (Million US$), 2020 – 2025
Figure 9_11: Australia – Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2013 – 2019
Figure 9_12: Australia – Forecast for Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_13: Australia – Blood Glucose Meter Market (Million US$), 2013 – 2019
Figure 9_14: Australia – Forecast for Blood Glucose Meter Market (Million US$), 2020 – 2025
Figure 9_15: Australia – Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2013 – 2019
Figure 9_16: Australia – Forecast for Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_17: Australia – Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2013 – 2019
Figure 9_18: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2020 – 2025
Figure 9_19: Australia – Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2013 – 2019
Figure 9_20: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2020 – 2025
Figure 14_7: Australia – Insulin Pen Users (Thousand), 2011 – 2019
Figure 14_8: Australia – Forecast for Insulin Pen Users (Thousand), 2020 – 2025
Figure 14_11: Australia – Disposable Insulin Pen Users (Thousands), 2011 – 2019
Figure 14_12: Australia – Forecast for Disposable Insulin Pen Users (Thousands), 2020 – 2025
Figure 14_15: Australia – Reusable Insulin Pen Users (Numbers), 2011 – 2019
Figure 14_16: Australia – Forecast for Reusable Insulin Pen Users (Numbers), 2020 – 2025
Figure 14_19: Australia – Smart Insulin Pen Users (Numbers), 2011 – 2019
Figure 14_20: Australia – Forecast for Smart Insulin Pen Users (Numbers), 2020 – 2025
Figure 14_5: Australia – Insulin Pen Market (Million US$), 2011 – 2019
Figure 14_6: Australia – Forecast for Insulin Pen Market (Million US$), 2020 – 2025
Figure 14_9: Australia – Disposable Insulin Pen Market (Million US$), 2011 – 2019
Figure 14_10: Australia – Forecast for Disposable Insulin Pen Market (Million US$), 2020 – 2025
Figure 14_13: Australia – Reusable Insulin Pen Market (Million US$), 2011 – 2019
Figure 14_14: Australia – Forecast for Reusable Insulin Pen Market (Million US$), 2020 – 2025
Figure 14_17: Australia – Smart Insulin Pen Market (Million US$), 2011 – 2019
Figure 14_18: Australia – Forecast for Smart Insulin Pen Market (Million US$), 2020 – 2025
Figure 14_21: Australia - Insulin Pen Needle Market (Million US$), 2011 – 2019
Figure 14_22: Australia - Forecast for Insulin Pen Needle Market (Million US$), 2020 – 2025
Figure 18_1: Australia – Insulin Pump Users (Number), 2011 – 2019
Figure 18_2: Australia – Forecast for Insulin Pump Users (Number), 2020 – 2025
Figure 18_3: Australia – Insulin Pump Users Type 1 & Type 2 (Number), 2011 – 2019
Figure 18_4: Australia – Forecast for Insulin Pump Users Type 1 & Type 2 (Number), 2020 – 2025
Figure 18_5: Australia – Insulin Pump Market (Million US$), 2015 – 2019
Figure 18_6: Australia – Forecast for Insulin Pump Market (Million US$), 2020 – 2025
Figure 18_7: Australia – Insulin Pump Market Type 1 & Type 2 (Million US$), 2015 – 2019
Figure 18_8: Australia – Forecast for Insulin Pump Market Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 12_1: Global – B. Braun Melsungen AG Revenue (Million US$), 2014 – 2019
Figure 12_2: Global – Forecast for B. Braun Melsungen AG Revenue (Million US$), 2020 – 2025
Figure 12_3: Global – Eli Lilly and Company Revenue (Million US$), 2014 – 2019
Figure 12_4: Global – Forecast for Eli Lilly and Company Revenue (Million US$), 2020 – 2025
Figure 12_5: Global – Artsana S.p.A. Revenue (Million US$), 2016 – 2019
Figure 12_6: Global – Forecast for Artsana S.p.A. Revenue (Million US$), 2020 – 2025
Figure 12_7: Global – Becton, Dickinson and Company Revenue (Million US$), 2014 – 2019
Figure 12_8: Global – Forecast for Becton, Dickinson and Company Revenue (Million US$), 2020 – 2025
Figure 12_9: Global – Novo Nordisk A/S Revenue (Million US$), 2015 – 2019
Figure 12_10: Global – Forecast for Novo Nordisk A/S Revenue (Million US$), 2020 – 2026
Figure 12_11: Global – Owen Mumford Ltd. Revenue (Million US$), 2011 – 2019
Figure 12_12: Global – Forecast for Owen Mumford Ltd. Revenue (Million US$), 2020 – 2026
Figure 12_13: Global – Ypsomed AG Revenue (Million US$), 2013 – 2019
Figure 12_14: Global – Forecast for Ypsomed AG Revenue (Million US$), 2020 – 2026
Figure 13_1: Global – Medtronic Insulin Pump Revenue (Million US$), 2014 – 2019
Figure 13_2: Global – Forecast for Medtronic Insulin Pump Revenue (Million US$), 2019 – 2025
Figure 13_3: Global – Insulet Corporation Insulin Pump Revenue (Million US$), 2014 – 2019
Figure 13_4: Global – Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2020 – 2025
Figure 14_1: Global – LifeScan SMBG Revenue (Million US$), 2014 – 2019
Figure 14_2: Global – Forecast for LifeScan SMBG Revenue (Million US$), 2020 – 2025
Figure 14_3: Global – Abbott Laboratories Diabetes Care Revenue (Million US$), 2014 – 2019
Figure 14_4: Global – Forecast for Abbott Laboratories Diabetes Care Revenue (Million US$), 2020 – 2025
Figure 15_1: Global – Dexcom Revenue (Million US$), 2014 – 2019
Figure 15_2: Global – Forecast for Dexcom Revenue (Million US$), 2020 – 2025


List of Tables


List of Tables:

Table 7_1: Australia – Diabetic Market Share by Types (Percent), 2013 – 2019
Table 7_2: Australia – Forecast for Diabetic Market Share by Types (Percent), 2020 – 2025
Table 11_1: Australia – Animas Vibe Differentiation Features
Table 11_2: Australia – Medtronic 530G with Enlite Differentiation Features
Table 11_3: Australia – Insulet OmniPod Differentiation Features
Table 11_4: Australia – Tandem t: slim Differentiation Features
Table 11_5: Australia – Roche Accu-Chek Combo Differentiation Features
Table 13_1: Medtronic – Latest Insulin Pump Products
Table 13_2: Acquisitions by Medtronic
Table 13_3: Insulet Corporation – Latest Products
Table 14_1: Acquisitions by Abbott